BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsMedicines for Cystic Fibrosis Treatment
    Awarded contract

    Medicines for Cystic Fibrosis Treatment

    Awarded
    €424.7k
    Published 25 Feb 2026

    This contract involves the procurement of various medicines specifically for the treatment of cystic fibrosis, including the combination of Ivacaftor, Tezacaftor, and Elexacaftor. The contract is valued at approximately €424,689.75 and is issued by the Health Services of the Autonomous Region of Mad

    🇵🇹PortugalPublished 25 Feb 2026· 5 months agoviaTED
    Awarded
    €424.7k
    Published 25 Feb 2026

    Decision brief

    4 fields
    • Contract value
      €424,690
      Euros
    • Closing date
      Rolling
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇵🇹Portugal

    Suppliers

    2 suppliers
    • VP
      VERTEX PHARMACEUTICALS PORTUGAL UNIPESSOAL LDA
    Lead contractor
  1. VP
    VERTEX PHARMACEUTICALS PORTUGAL UNIPESSOAL LDA
    Consortium partner
  2. Lifecycle

    Awarded

    Contract awarded. Originally published 5 months ago.

    25 February 2026
    Awarded — no open tender advertised

    Brief

    This contract involves the procurement of various medicines specifically for the treatment of cystic fibrosis, including the combination of Ivacaftor, Tezacaftor, and Elexacaftor. The contract is valued at approximately €424,689.75 and is issued by the Health Services of the Autonomous Region of Madeira (SESARAM). Suppliers are invited to provide these essential medications to support patients in need. For more details, please visit the contract platform at TED.

    Track record

    3 awards · 3 winners
    Open field

    No single supplier dominates the field.

    In healthcare medical, HEALTH SERVICES OF THE AUTONOMOUS REGION OF MADEIRA EPERAM SESARAM EPERAM has awarded 3 contracts to 3 suppliers.

    Who wins here
    1. SANOFI PHARMACEUTICAL PRODUCTS LTD1× · 33%
    2. FRESENIUS MEDICAL CARE PORTUGAL SA1× · 33%
    3. VERTEX PHARMACEUTICALS PORTUGAL UNIPESSOAL LDA1× · 33%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from HEALTH SERVICES OF THE AUTONOMOUS REGION OF MADEIRA EPERAM SESARAM EPERAM

    2 listingsView all →
    AwardedHealthcare & Medical🇵🇹Portugal

    Enzymatic Substitutes for Alpha-Glucosidase

    The Regional Health Services of Madeira (SESARAM) are seeking suppliers for enzymatic substitutes specifically for alpha-glucosidase. This procurement opportunity is focused on acquiring various medications that serve as enzymatic substitutes, which are essential for treating specific health conditi

    €340,716HEALTH SERVICES OF THE AUTONOMOUS REGION OF MADEIRA EPERAM SESARAM EPERAM
    Published 27 Nov 2025
    AwardedHealthcare & Medical🇵🇹Portugal

    Peritoneal Dialysis Kits

    This contract opportunity is for the supply of peritoneal dialysis kits. The buyer, Serviços de Saúde da Região Autónoma da Madeira, is seeking suppliers to provide these essential medical supplies. The total value of the contract is €231,200. Interested suppliers can find more details and apply thr

    €231,200HEALTH SERVICES OF THE AUTONOMOUS REGION OF MADEIRA EPERAM SESARAM EPERAM
    Published 4 Aug 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Doxycycline 10-Pack Supply - Market Engagement 2027

    UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 21 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Patient Diagnostic and Monitoring Electrodes - Market Engagement Survey

    Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.

    Business Services Organisation Procurement and Logistics
    Published 21 Aug 2026
    Take action
    View on sourceTED

    Award notice and full record on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    137831-2026
    HS
    Buyer
    HEALTH SERVICES OF THE AUTONOMOUS REGION OF MADEIRA EPERAM SESARAM EPERAM
    Sector
    Healthcare & Medical